The Australian Research Data Commons (ARDC) invites you to participate in a short survey about your
interaction with the ARDC and use of our national research infrastructure and services. The survey will take
approximately 5 minutes and is anonymous. It’s open to anyone who uses our digital research infrastructure
services including Reasearch Link Australia.
We will use the information you provide to improve the national research infrastructure and services we
deliver and to report on user satisfaction to the Australian Government’s National Collaborative Research
Infrastructure Strategy (NCRIS) program.
Please take a few minutes to provide your input. The survey closes COB Friday 29 May 2026.
Complete the 5 min survey now by clicking on the link below.
Prof McGuckin is studying common chronic diseases (gut and respiratory inflammatory diseases, arthritis, and obesity and diabetes) that are major contributors to poor health in the Australian community and are major contributors to healthcare expenditure. His research includes basic studies elucidating the biological basis of these diseases and then uses this new knowledge to develop new therapeutic approaches to treatment. The new therapeutic approaches will be tested in model systems as a prel ....Prof McGuckin is studying common chronic diseases (gut and respiratory inflammatory diseases, arthritis, and obesity and diabetes) that are major contributors to poor health in the Australian community and are major contributors to healthcare expenditure. His research includes basic studies elucidating the biological basis of these diseases and then uses this new knowledge to develop new therapeutic approaches to treatment. The new therapeutic approaches will be tested in model systems as a prelude to clinical trials.Read moreRead less
My primary research focus is to understand the mechanisms underlying sleep-related breathing disorders, such as obstructive sleep apnoea, and develop better ways to diagnose and treat them. I also investigate physical therapies to improve the lives of people with chronic lung disease. Both sleep disorders and lung disease are extremely common in Australia. Improving the health and quality of life of these individuals has important personal benefit and social and economic benefits.
Sleep Disorders And Human Health - Prevalence, Pathogenesis, Diagnosis And Treatment
Funder
National Health and Medical Research Council
Funding Amount
$640,210.00
Summary
My primary research focus is to understand the mechanisms underlying sleep-related breathing disorders, such as obstructive sleep apnoea, and develop better ways to diagnose and treat them. I do this by undertaking university-based epidemiology studies in a large sample of community participants, by undertaking smaller hospital-based physiology studies and by working with US and Australian start-up companies to design and test new treatment for sleep disorders.
Inflammatory Airway Diseases In Children: Mechanisms Underlying And Preventative Strategies
Funder
National Health and Medical Research Council
Funding Amount
$823,008.00
Summary
Professor Sly’s research concentrates on understanding why some children develop chronic lung disease and on finding ways to prevent this from happening.
Regulation Of Nucleocytoplasmic Transport; Role In Health And Disease
Funder
National Health and Medical Research Council
Funding Amount
$823,008.00
Summary
Transport into and out of the nucleus is central to the function of the cells from complex organisms such as mammals. This research program aims to improve understanding of nuclear transport and its regulation in the context of infection by medically relevant viruses, as well as in the context of cancer, and normal cell growth/development. It will contribute to developing new anti-viral therapeutics/vaccines, drug delivery strategies for cancer, and understanding causes of male infertility.
Nuclear Transport In Health And Disease; Towards Therapeutics
Funder
National Health and Medical Research Council
Funding Amount
$851,980.00
Summary
This research fellowship will enable new therapeutic approaches to viral disease and cancer that target the transport process. I have already licenced an inhibitory molecule for Dengue virus which is progressing towards the clinic. I will now extend my research into a vibrant translational program of developing anti-viral (HIV, Respiratory Syncytical Virus, VEEV) as well as anti-cancer agents that will represent realistic therapeutic options in the near future.
This Fellowship will provide support for the Marshall Centre which is providing research and research training in the fields of bacteriology, epidemiology and vaccinology. It has significant regional collaborative links. Molecular epidemiology and pathogenesis of Helicobacter pylori, the stomach bacteria which causes ulcers and for which Warren and Marshall won the 2005 Nobel Prize in Medicine. Development of animal models to study the immune response so that the new bacterium can be used as a v ....This Fellowship will provide support for the Marshall Centre which is providing research and research training in the fields of bacteriology, epidemiology and vaccinology. It has significant regional collaborative links. Molecular epidemiology and pathogenesis of Helicobacter pylori, the stomach bacteria which causes ulcers and for which Warren and Marshall won the 2005 Nobel Prize in Medicine. Development of animal models to study the immune response so that the new bacterium can be used as a vaccine delivery agent.Read moreRead less
Spatiotemporal Risk Assessment Of Emerging Infectious Disease Threats To Australia
Funder
National Health and Medical Research Council
Funding Amount
$641,204.00
Summary
Emerging infectious diseases (EIDs) such as dengue and influenza pose a constant and growing threat to Australians. We live in an increasingly connected world in which EIDs cross borders and oceans, carried by infected people or vectors. This research will build an evidence base for allocation of resources to surveillance and preventive health programmes aimed at mitigating the threat of EIDs, through identifying high-risk sources, routes of introduction, incursion locations and communities.
Pathogenic Flaviviruses: Molecular Mechanisms Of Disease, Host Response And Vaccines
Funder
National Health and Medical Research Council
Funding Amount
$697,209.00
Summary
The application is aimed at advancing our understanding of the viral and host processes determining outcome of infection with pathogenic flaviviruses (i.e. West Nile virus) to the level allowing most comprehensive design of effective vaccines and anti-viral drugs. One of the aims is also to develop novel viral delivery vectors for cancer therapy based on self-replicating RNA of an attenuated Australian strain of West Nile virus, Kunjin.
Birth is one of the greatest physiological challenges that we will ever experience and so it is not surprising that it is a period of high risk of death. Despite the risk, our understanding of how infants transition from fetal to newborn life is limited. My research is focused on improving our understanding of how infants make the transition at birth so that we can reduce the risks for these most vulnerable of humans. In particular, I want to improve outcomes for infants born very premature.